Gastrointestinal OTC Drugs Market 2026–2035 driven by self-medication trends

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market During 2026–2030?

The gastrointestinal over-the-counter (otc) drugs market size has experienced robust growth in recent years. It is anticipated to increase from $49.59 billion in 2025 to $53.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.4%. This historic expansion is largely due to digestive disorder prevalence, otc drug accessibility, pharmacy retail expansion, urban lifestyle changes, and dietary habit shifts.

The gastrointestinal over-the-counter (otc) drugs market is anticipated to experience robust expansion in the coming years. This market is projected to reach $73.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. Key factors driving this growth during the forecast period include the increasing adoption of preventive digestive care, the expansion of e-commerce, a rising demand for clean-label OTC products, the growing aging population, and heightened awareness regarding digestive health. Significant trends observed within the forecast period encompass an increase in self-medication for digestive issues, an escalating demand for rapid-acting OTC relief, a greater utilization of combination gastrointestinal products, the widespread expansion of online pharmacy sales, and an emerging preference for herbal and enzyme-based products.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp

Which Economic Or Industry Drivers Are Impacting The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

The expanding incidence of digestive disorders is projected to fuel the growth of the gastrointestinal OTC drugs market. These conditions encompass various ailments impacting the gastrointestinal tract, including the stomach, intestines, and related organs. A primary reason for the rise in digestive disorders is the increased consumption of processed, low-fiber foods, which adversely affect gut health and digestion. Gastrointestinal OTC drugs mitigate symptoms of digestive issues by lowering stomach acid, normalizing bowel movements, and improving overall gut health, offering quick and convenient relief for common problems such as acidity, constipation, and indigestion. For instance, in December 2023, the IBD Registry Ltd., a UK-based non-profit organization, reported that individuals with inflammatory bowel disease (IBD) exceeded 5,300, representing an increase of over 3,000 members compared to 2022. Consequently, the growing prevalence of digestive disorders is a key factor propelling the expansion of the gastrointestinal OTC drugs market.

How Are The Various Segments Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market Categorized?

The gastrointestinal over-the-counter (otc) drugs market covered in this report is segmented –

1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products

2) By Formulation: Tablets, Capsules, Liquids, Other Formulations

3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids

2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives

3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions

4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements

5) By Other Products: Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal

What Trends Are Affecting The Expansion Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

Leading entities operating in the gastrointestinal OTC drugs market are concentrating on developing advanced products, such as OTC proton pump inhibitors, to offer effective and prolonged relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a category of medications accessible without a prescription that reduce stomach acid production. They are commonly employed to manage conditions including frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a pharmaceutical company based in Japan, obtained approval in Japan to reclassify its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status. This made it the first OTC PPI in Japan to contain the same active ingredient and dosage as the prescription version. Pariet S is indicated for stomach pain, heartburn, and bloating, delivering 24-hour relief with a once-daily, easy-to-swallow tablet, and seeks to address the increasing requirement for effective gastric acid-related treatments stemming from lifestyle and demographic shifts.

Which Major Firms Influence Developments In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

Major companies operating in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd.

Read the full gastrointestinal over-the-counter (otc) drugs market report here:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-over-the-counter-otc-drugs-global-market-report

What Are The Top-Performing Regions Within The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (otc) drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastrointestinal Over-The-Counter (OTC) Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24547&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Over-The-Counter (OTC) Drugs Market 2026, By The Business Research Company

Colorectal Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Otc Drug And Dietary Supplement Market Report 2026

https://www.thebusinessresearchcompany.com/report/otc-drug-and-dietary-supplement-global-market-report

Gastroparesis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795